Deutsch English Français

Contact

EP1244447

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1244447

EP1244447 - NOVEL METHODS AND COMPOSITIONS INVOLVING OPIOIDS AND ANTAGONISTS THEREOF [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 16.11.2007 Database last updated on 24.04.2024
Most recent event Tooltip	16.11.2007	No opposition filed within time limit	published on 19.12.2007 [2007/51]
Applicant(s)	For all designated states Adolor Corporation 700 Pennsylvania Drive Exton, PA 19341-1127 / US
	[2007/11]
Former [2002/40]	For all designated states Adolor Corporation 620 Pennsylvania Drive Exton, PA 19341-1127 / US
Inventor(s)	01 / FARRAR, John, J. 1066 Bodine Road Chester Springs, PA 19425 / US
	[2002/40]
Representative(s)	WP Thompson 138 Fetter Lane London EC4A 1BT / GB
	[N/P]
Former [2002/40]	W.P. THOMPSON & CO. Eastcheap House Central Approach Letchworth, Hertfordshire SG6 3DS / GB
Application number, filing date	00992256.8	29.11.2000
	[2002/40]
	WO2000US42315
Priority number, date	US19990450806	29.11.1999 Original published format: US 450806
	[2002/40]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO0137785
	Date:	31.05.2001
	Language:	EN
	[2001/22]
	Type:	A2 Application without search report
	No.:	EP1244447
	Date:	02.10.2002
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 31.05.2001 takes the place of the publication of the European patent application.
	[2002/40]
	Type:	B1 Patent specification
	No.:	EP1244447
	Date:	10.01.2007
	Language:	EN
	[2007/02]
Search report(s)	International search report - published on:	US	10.01.2002
	(Supplementary) European search report - dispatched on:	EP	25.04.2003
Classification	IPC:	A61K31/445, A61K31/485	[2003/22]
	CPC:	A61K31/4748 (EP); A61K31/445 (EP); A61K31/485 (EP); A61P1/00 (EP); A61P25/02 (EP); A61P43/00 (EP)
	C-Set:	A61K31/445, A61K2300/00 (EP); A61K31/4748, A61K2300/00 (EP); A61K31/485, A61K2300/00 (EP)
	Former IPC [2002/40]	A61K31/445
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2002/40]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	NEUE VERFAHREN UND ZUBEREITUNGEN DIE OPIOIDEN UND DEREN ANTAGONISTEN ENTHALTEN	[2002/40]
	English:	NOVEL METHODS AND COMPOSITIONS INVOLVING OPIOIDS AND ANTAGONISTS THEREOF	[2002/40]
	French:	NOUVEAUX PROCEDES ET NOUVELLES COMPOSITIONS COMPRENANT DES OPIOIDES ET DES ANTAGONISTES D'OPIOIDES	[2002/40]
Entry into regional phase	28.06.2002	National basic fee paid
	28.06.2002	Search fee paid
	28.06.2002	Designation fee(s) paid
	28.06.2002	Examination fee paid
Examination procedure	04.06.2001	Request for preliminary examination filed International Preliminary Examining Authority: US
	28.06.2002	Examination requested [2002/40]
	19.08.2002	Amendment by applicant (claims and/or description)
	16.07.2003	Despatch of a communication from the examining division (Time limit: M06)
	04.03.2004	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	14.04.2004	Reply to a communication from the examining division
	02.02.2005	Despatch of a communication from the examining division (Time limit: M06)
	03.08.2005	Reply to a communication from the examining division
	30.03.2006	Date of oral proceedings
	12.04.2006	Minutes of oral proceedings despatched
	15.05.2006	Communication of intention to grant the patent
	13.09.2006	Fee for grant paid
	13.09.2006	Fee for publishing/printing paid
Opposition(s)	11.10.2007	No opposition filed within time limit [2007/51]
Request for further processing for:	14.04.2004	Request for further processing filed
	14.04.2004	Full payment received (date of receipt of payment) Request granted
	25.05.2004	Decision despatched
Fees paid	Renewal fee
	28.06.2002	Renewal fee patent year 03
	12.11.2003	Renewal fee patent year 04
	12.11.2004	Renewal fee patent year 05
	14.11.2005	Renewal fee patent year 06
	14.11.2006	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]US4457933 (GORDON MAXWELL [US], et al) [X] 1-42 * column 1, line 20 - line 31; example -; claim - *;
		[X]US4582835 (LEWIS JOHN W [GB], et al) [X] 1-42 * examples 1-7; claim - *;
		[X]US4769372 (KREEK MARY J [US]) [X] 1-42 * column 2, line 65 - column 3, line 9; claim - *;
		[X]EP0287339 (LILLY CO ELI [US]) [X] 1-42 * page 28, line 28 - line 38; claims 7,8; table 2 *;
		[X] - WITTELS B ET AL, "OPIOID ANTAGONIST ADJUNCTS TO EPIDURAL MORPHINE FOR POSTCESAREAN ANALGESIA: MATERNAL OUTCOMES", ANESTHESIA AND ANALGESIA, WILLIAMS AND WILKINS, BALTIMORE, MD, US, (199311), vol. 77, no. 5, ISSN 0003-2999, pages 925 - 932, XP001095958 [X] 1-42 * page 925 * * page 926, column L, paragraph 3 * * page 930, column R, paragraph L - page 931, column L, paragraph 1 *
		[X] - GERAK L R ET AL, "CHANGES IN SENSITIVITY TO THE RAT-DECREASING EFFECTS OF OPIODIS IN PIGEONS TREATED ACUTELY OR CHRONICALLY WITH NALBUPHINE", BEHAVIOURAL PHARMACOLOGY, RAPID SCIENCE, PUBLISHERS, GB, (199610), vol. 5, no. 7, ISSN 0955-8810, pages 437 - 447, XP008005675 [X] 1-42 * page 439, column L, paragraph 2; figure 1 *
		[XP] - GEAR R W ET AL, "ACTION OF NALOXONE ON GENDER-DEPENDENT ANALGESIC AND ANTIANALGESIC EFFECTS OF NALBUPHINE IN HUMANS", JOURNAL OF PAIN, SAUNDERS, PHILADELPHIA, PA, US, (20000621), vol. 1, no. 2, ISSN 1526-5900, pages 122 - 127, XP008005634 [XP] 1-42 * page 123, column L, line 4 - line 5; table 1 * DOI: http://dx.doi.org/10.1016/S1526-5900(00)90097-X
		[PX] - VACCARINO A L ET AL, "Endogenous opiates: 1998.", PEPTIDES. UNITED STATES DEC 1999, (199912), vol. 20, no. 12, ISSN 0196-9781, pages 1527 - 1574, XP002236928 [PX] 1-42 * page 1543, column R, lines 5-8 * DOI: http://dx.doi.org/10.1016/S0196-9781(99)00166-7
	International search	[Y]US5250542 (CANTRELL BUDDY E [US], et al);
		[Y] - "Opiate analgesics", OSOL, Remington's pharmaceutical sciences, (1975), page 1098, XP001149582 [Y] * 15th Edition; page 1098 *
		[Y] - WINDHOLZ, The merck index, an encyclopedia of chemicals, drugs and biologicals, (19860721), XP002942738 [Y] * 10th edition, no. 2423; page 350 *
	Examination	- "Adolor targets pain/itch", WORLD PHARMACEUTICAL NEWS, (19990212), no. 2412
		- "Adolor to Develop Copound to Treat Narcotic-Induced Constipation; In-licensed From Roberts Pharmaceuticals", PR NEWSWIRE, (19980616), page 0616NYTU019
		- ZIMMERMANN ET AL, DRUGS OF THE FUTURE, (1994), vol. 19, no. 12, pages 1078 - 1083

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p